Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$459.92
$459.06
$274.98
$503.24
$809.46M0.6923,283 shsN/A
Neogen Co. stock logo
NEOG
Neogen
$6.49
-0.2%
$6.97
$3.87
$18.58
$1.41B1.832.95 million shs6.28 million shs
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$35.51
-5.1%
$31.36
$23.77
$49.45
$2.40B0.131.07 million shs1.60 million shs
STAAR Surgical stock logo
STAA
STAAR Surgical
$19.00
-6.3%
$17.63
$13.50
$49.86
$940.99M0.65808,210 shs914,394 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%0.00%0.00%0.00%+4.60%
Neogen Co. stock logo
NEOG
Neogen
-0.15%+18.21%+16.31%-34.77%-49.45%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-5.10%+36.89%+31.96%-11.09%-15.67%
STAAR Surgical stock logo
STAA
STAAR Surgical
-6.27%+1.93%+13.16%+15.29%-56.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/AN/AN/AN/AN/A
Neogen Co. stock logo
NEOG
Neogen
3.2863 of 5 stars
3.31.00.00.02.53.32.5
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
4.3416 of 5 stars
2.24.00.03.83.41.72.5
STAAR Surgical stock logo
STAA
STAAR Surgical
3.6982 of 5 stars
3.01.00.04.12.03.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
0.00
N/AN/AN/A
Neogen Co. stock logo
NEOG
Neogen
2.50
Moderate Buy$9.0038.67% Upside
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
2.43
Hold$44.3324.85% Upside
STAAR Surgical stock logo
STAA
STAAR Surgical
2.00
Hold$24.6329.61% Upside

Current Analyst Ratings Breakdown

Latest ATRI, QDEL, NEOG, and STAA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$45.00 ➝ $29.00
5/8/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$44.00
5/8/2025
STAAR Surgical stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$17.00 ➝ $20.00
4/22/2025
Neogen Co. stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.40 ➝ $5.00
4/21/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$38.00 ➝ $25.00
4/21/2025
STAAR Surgical stock logo
STAA
STAAR Surgical
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$17.00
4/14/2025
Neogen Co. stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.00 ➝ $6.50
4/10/2025
Neogen Co. stock logo
NEOG
Neogen
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $13.00
3/18/2025
STAAR Surgical stock logo
STAA
STAAR Surgical
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$17.00 ➝ $17.00
2/27/2025
STAAR Surgical stock logo
STAA
STAAR Surgical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 5/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$181.60M4.46$19.68 per share23.37$138.02 per share3.33
Neogen Co. stock logo
NEOG
Neogen
$906.00M1.55$0.66 per share9.80$14.52 per share0.45
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$2.78B0.86$27.53 per share1.29$44.75 per share0.79
STAAR Surgical stock logo
STAA
STAAR Surgical
$279.13M3.37$0.83 per share23.02$7.91 per share2.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$10.6443.23N/A10.60%7.75%7.12%N/A
Neogen Co. stock logo
NEOG
Neogen
-$9.42M-$2.23N/A13.24N/A-52.12%2.89%1.98%7/29/2025 (Estimated)
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-$2.03B-$4.97N/A11.06N/A-72.84%3.78%1.80%7/30/2025 (Estimated)
STAAR Surgical stock logo
STAA
STAAR Surgical
-$20.21M-$1.44N/AN/AN/A-6.44%-3.35%-2.67%N/A

Latest ATRI, QDEL, NEOG, and STAA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$0.61$0.74+$0.13-$0.19$694.97 million$692.80 million
4/9/2025Q3 2025
Neogen Co. stock logo
NEOG
Neogen
$0.12$0.10-$0.02-$0.05$225.27 million$221.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.801.91%+9.65%82.71%21 Years
Neogen Co. stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A
STAAR Surgical stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.18
3.06
Neogen Co. stock logo
NEOG
Neogen
0.33
3.77
2.46
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.71
1.22
0.69
STAAR Surgical stock logo
STAA
STAAR Surgical
N/A
5.99
5.38

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Neogen Co. stock logo
NEOG
Neogen
96.73%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
99.00%
STAAR Surgical stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
Neogen Co. stock logo
NEOG
Neogen
1.13%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.79%
STAAR Surgical stock logo
STAA
STAAR Surgical
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7201.76 million1.36 millionNot Optionable
Neogen Co. stock logo
NEOG
Neogen
2,110217.04 million214.49 millionOptionable
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
7,00067.46 million66.58 millionOptionable
STAAR Surgical stock logo
STAA
STAAR Surgical
96049.53 million48.78 millionOptionable

Recent News About These Companies

Brokerages Set STAAR Surgical (NASDAQ:STAA) PT at $24.63

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Atrion stock logo

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Neogen stock logo

Neogen NASDAQ:NEOG

$6.49 -0.01 (-0.15%)
As of 05/13/2025 04:00 PM Eastern

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

QuidelOrtho stock logo

QuidelOrtho NASDAQ:QDEL

$35.51 -1.91 (-5.10%)
As of 05/13/2025 04:00 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$19.00 -1.27 (-6.27%)
As of 05/13/2025 04:00 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.